ImpriMed
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $37M
Investors
- 23
About ImpriMed
Based in California, US, ImpriMed, Inc. is a developer of customized drug response testing solutions for pet cancer patients. Founded in 2017 by Sungwon Lim (CEO) and Jamin Koo (CTO), the company collects test results and builds a database of patient cell responses to FDA-approved drugs to support the development of personalized therapeutic regimens. In September 2026, ImpriMed, Inc. ImpriMed, Inc. develops artificial intelligence-powered precision medicine solutions that help identify the most effective cancer treatments for individual patients. Its offerings include drug response prediction services, live-cell drug sensitivity testing, and research services that support oncology drug development for pharmaceutical and biotechnology companies. The company generates revenue through veterinary oncology diagnostic and drug-response testing services, human precision medicine analytics, and contract research (CRO) services provided to pharmaceutical companies.
Who invested in ImpriMed
23 investors across 3 rounds
See all investors in ImpriMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ImpriMed
Who invested in ImpriMed?
ImpriMed has 23 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImpriMed raised?
ImpriMed has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ImpriMed last raise money?
ImpriMed's most recent round on record is a Series A, in Sep 2026.
What does ImpriMed do?
Based in California, US, ImpriMed, Inc.
Where is ImpriMed headquartered?
ImpriMed is headquartered in Palo Alto, US.
Which VCs invest in companies like ImpriMed?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ImpriMed's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ImpriMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.